Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Effect of Dexmedetomidine as Immunomodulatory Anesthesic Agent in Patients Undergoing to Spinal Fusion: a Double-blind, Randomized and Placebo-controlled Clinical Trial

NCT02854904 is registered in ClinicalTrials.gov with Sarah Network of Rehabilitation Hospitals as lead sponsor.

NCT NCT02854904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02854904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Effect of Dexmedetomidine as Immunomodulatory Anesthesic Agent in Patients Undergoing to Spinal Fusion: a Double-blind, Randomized and Placebo-controlled Clinical Trial
Lead sponsor
Sarah Network of Rehabilitation Hospitals
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 31, 2016
Completion date
June 30, 2017
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spine; arthrosis, spondylolisthesis, spondylolysis, spondylolysis, multiple sites in spine